Tapcin
Product Specifications
UNSPSC Description
Tapcin is a dual inhibitor for topoisomerase I and topoisomerase II, with IC50 of 203 and 71 nM. Tapcin inhibits proliferations of cancer cells A-375, HeLa, Huh7.5, U2-OS, A549, Caco-2 and HT29, with IC50s of 441, 1.04, 40.5, 0.002, 0.006, 0.287 and 0.842 nM, respectively. Tapcin exhibits antitumor activity in HT29 xenograft model[1].
Target Antigen
Topoisomerase
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tapcin.html
Smiles
O=C([C@H](C)NC([C@H](C)NC(CC(O)CCCCCCCCCCC)=O)=O)NC1=CC=C(C2=NC(C3=NC(C4=NC(C(N[C@H](C(NC5=CC=C(C(NC6=C(OC(C)C)C(O)=C(C(NC7=CC=C(C(O)=O)C=C7)=O)C=C6)=O)C=C5)=O)CC(N)=O)=O)=CS4)=CS3)=CS2)C=C1
Molecular Weight
1300.53
References & Citations
[1]Wang Z, et al., Tapcin, an In Vivo Active Dual Topoisomerase I/II Inhibitor Discovered by Synthetic Bioinformatic Natural Product (Syn-BNP)-Coupled Metagenomics. Angew Chem Int Ed Engl. 2024 Apr 22;63(17):e202317187.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-161628/Tapcin-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-161628/
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
abx273959-01 200 µL
Platelet-Activating Factor Acetylhydrolase (PLA2G7) Antibody (FITC)
Ask
View Details abx273959-02 1 mL
Platelet-Activating Factor Acetylhydrolase (PLA2G7) Antibody (FITC)
Ask
View Details 
